Paul K. Audhya is CHIEF MEDICAL OFFICER of KalVista Pharmaceuticals, Inc.. Currently has a direct ownership of 102,940 shares of KALV, which is worth approximately $1.12 Million. The most recent transaction as insider was on Nov 17, 2022, when has been sold 2,419 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 103K
6.11% 3M change
94.65% 12M change
Total Value Held $1.12 Million

Paul K. Audhya Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 17 2022
BUY
Exercise of conversion of derivative security
-
2,419 Added 26.62%
6,668 Common Stock
Aug 17 2022
SELL
Open market or private sale
$10,846 $14.96 p/Share
725 Reduced 29.98%
1,693 Common Stock
Aug 17 2022
BUY
Exercise of conversion of derivative security
-
2,418 Added 50.0%
2,418 Common Stock
PKA

Paul K. Audhya

CHIEF MEDICAL OFFICER
Cambridge, MA

Track Institutional and Insider Activities on KALV

Follow KalVista Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KALV shares.

Notify only if

Insider Trading

Get notified when an Kal Vista Pharmaceuticals, Inc. insider buys or sells KALV shares.

Notify only if

News

Receive news related to KalVista Pharmaceuticals, Inc.

Track Activities on KALV